What's Happening?
Mozza Foods, a California-based startup, is targeting a late 2028 launch for its soybean-grown casein proteins, contingent on receiving necessary approvals from the USDA and FDA. The company has submitted a petition to the USDA to assess whether its genetically
modified crops pose a plant pest risk and plans to submit a Generally Recognized as Safe (GRAS) application to the FDA next year. Mozza Foods aims to achieve cost parity with traditional dairy by leveraging existing agricultural infrastructure and has been conducting field trials to improve protein expression levels in soybeans.
Why It's Important?
Mozza Foods' initiative represents a significant development in the alternative protein industry, which seeks to provide sustainable and ethical alternatives to traditional animal agriculture. Achieving regulatory approval and cost parity could position Mozza Foods as a leader in the market, potentially influencing dairy industry practices and consumer choices. The company's focus on molecular farming and crop segregation technology highlights the growing importance of innovation in achieving food security and sustainability goals.
What's Next?
Mozza Foods is awaiting responses from the USDA and FDA regarding its regulatory submissions. Successful approvals would allow the company to proceed with its planned launch, potentially expanding its market presence and partnerships with major dairy manufacturers. The company is also raising additional funds to support its growth and achieve cost parity, which could attract further investment and interest in the alternative protein sector.
